Correlation between Histopathological Type and Grade of Different Ovarian Tumors with Their Blood CA125 Levels
Journal Title: Journal of Medical Science And clinical Research - Year 2015, Vol 3, Issue 2
Abstract
Introduction: Women with ovarian carcinoma experience poor survival because symptoms are vague and diagnosis is unlikely at an early stage. Early detection is utmost important both for treatment and survival CA-125 is the most frequently used biomarker for ovarian cancer detection. In this study, the authors evaluated 60 distinct cases of benign and malignant primary ovarian tumors, of different cell lines and degrees of differentiation, aimed at assessing the relationship between serum levels of CA125 and the biological behavior and/or the histological degree of these neoplasms. Materials & Methods: patients were selected for study after clinical suspicion fallowed by radiological evaluation .Serum sample for CA 125 sent preoperatively. Patients were operated and ovarian tissue sent for histopathological examination for typing and grading in pathology department. The study carried out with sixty patients for one year duration. Results: After histopathological examination it was confirmed that 37 (61.6%) cases were suffering from benign ovarian tumor. 6 (10%) cases were suffering from borderline ovarian tumor and 17 (28.3%) cases from malignant ovarian tumor. Majority of patients with benign tumor (35/37, 94.59%) have their serum CA125 value <35 U/ml and most of patients with borderline & malignant tumors (18/23, 78.2%) have their serum CA125 value >35 U/ml. Again 7/17 (41.17%) of patients with malignant tumor have their serum CA125 value > 100 U/ml. 100% of patient with borderline tumors have their serum CA125 value in between 35-65 U/ml. The present study revealed that 100% of the patient having epithelial borderline/malignant tumors of grade I had their serum CA125 values within 35-65 U/ml. (6/7, 85.7%) of patients having epithelial borderline/ malignant tumor of grade III had their serum CA125 values >100 U/ml. Another important finding was that epithelial malignant tumor including Mucinous cystadenocarcinoma, Serous cystadenocarcinoma had their mean value more than 100 IU. Conclusion: Patients with borderline/malignant epithelial tumor had higher pre-operative serum CA125 value (>35U/ml) than benign ovarian tumors.CA125 had ascending relation with higher grade of tumor. With very high value of serum CA 125, one should think about serous or mucinous epithelial ovarian tumor.
Authors and Affiliations
Dr. Samir Kumar Roy
Keywords
Related Articles
- EP ID EP210659
- DOI -
- Views 68
- Downloads 0
Precancerous Risk Assessment of the Gastric Atrophy by Tri-modal Endoscopy
Background / Aims: Gastritis staging and detection of pre-neoplastic gastric mucosal changes based on the histology of biopsy specimen imposes a considerable burden on endoscopist and pathologist. Therefore, we attempted...
Prevalence of Hypothyroidism in Adults in Kashmir Valley
Background: Hypothyroidism is one of the most common and treatable endocrine disease in which there is insufficient amount of thyroid hormones in body. Iodine deficiency remains the most common cause of hypothyroidism wo...
A Review of Spectrum of Breast Lesions in a Tertiary Care Centre: A Retrospective Study
Background: Breast lesions comprise a family of heterogeneous entities with variable patterns of presentation, morphology and clinical behaviour. The majority of breast lesions are traditionally classified into benign an...
Incidence of AUB as a Reason of Hysterectomy: A One Year Study
Background: Abnormal uterine bleeding (AUB) is a common and debilitating condition with high direct and indirect costs. Objectives of this study are –To study incidence of AUB in all cases of elective hysterectomy & to s...
Comparative Study between Exteriorization of Uterus during Caesarean Section versus Intra Peritoneal or In-Situ Repair
Caesarean delivery defines the birth of a foetus via laparotomy and then hysterotomy. It is the delivery of an infant, alive or dead, through an abdominal uterine incision after period of viability. From 1996 to 2011, th...